Go Pro

Marchex (NASDAQ:MCHX) Share Price Passes Above Two Hundred Day Moving Average - What's Next?

Marchex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Marchex shares moved above their 200-day moving average, reaching $1.80 before last trading at $1.74, compared with the $1.61 long-term average.
  • Analyst sentiment remains weak: one analyst rates the stock Hold and another Sell, resulting in an average “Reduce” rating. Weiss Ratings also maintained its “sell (d-)” assessment.
  • The company’s latest quarterly results missed expectations, with an adjusted loss of $0.03 per share versus estimates of a $0.01 loss and revenue of $10.62 million versus $10.89 million expected.
  • MarketBeat previews the top five stocks to own by September 1st.

Marchex, Inc. (NASDAQ:MCHX - Get Free Report)'s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.61 and traded as high as $1.80. Marchex shares last traded at $1.74, with a volume of 7,227 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Marchex in a research report on Friday, July 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Reduce".

Get Our Latest Analysis on Marchex

Marchex Stock Down 2.8%

The company has a market cap of $77.08 million, a price-to-earnings ratio of -15.82 and a beta of 1.90. The stock's 50-day simple moving average is $1.67 and its 200 day simple moving average is $1.61.

Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The technology company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). The company had revenue of $10.62 million for the quarter, compared to analyst estimates of $10.89 million. Marchex had a negative net margin of 11.15% and a negative return on equity of 14.61%. On average, sell-side analysts expect that Marchex, Inc. will post 0.01 EPS for the current fiscal year.

Institutional Trading of Marchex

Several institutional investors have recently added to or reduced their stakes in the stock. Kanen Wealth Management LLC raised its position in Marchex by 4.1% in the first quarter. Kanen Wealth Management LLC now owns 1,300,388 shares of the technology company's stock valued at $2,016,000 after purchasing an additional 50,989 shares during the period. Acuitas Investments LLC purchased a new position in shares of Marchex during the first quarter worth $207,000. Manatuck Hill Partners LLC purchased a new position in shares of Marchex during the second quarter worth $88,000. Jane Street Group LLC acquired a new stake in shares of Marchex in the first quarter valued at $30,000. Finally, XTX Topco Ltd acquired a new stake in shares of Marchex in the fourth quarter valued at $26,000. Institutional investors and hedge funds own 73.46% of the company's stock.

About Marchex

(Get Free Report)

Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines